Products for Research Use Only
RegisterLogin

Daratumumab

CAT: 0804-HY-P9915-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P9915-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Daratumumab (Anti-Human CD38) is the first-in-class human-specific anti-CD38 monoclonal antibody (IgG1) . Daratumumab has anti-multiple myeloma (MM) effect. Daratumumab impairs MM cell adhesion, which results in an increased sensitivity of MM to proteasome inhibition[1][2].
CAS Number
945721-28-8
Product Name Alternative
Anti-Human CD38, Human Antibody; HuMax-CD38; JNJ-54767414
UNSPSC
12352203
Target
ADC Antibody; CD38
Type
Inhibitory Antibodies
Related Pathways
Antibody-drug Conjugate/ADC Related; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/daratumumab.html
Purity
99.10
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
[Daratumumab]
Molecular Weight
(145.26 kDa)
References & Citations
[1]Ghose J, Viola D, et al. Daratumumab induces CD38 internalization and impairs myeloma cell adhesion. Oncoimmunology. 2018;7 (10) :e1486948. Published 2018 Jul 23.|[2]de Weers M, et al. Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. J Immunol. 2011;186 (3) :1840-1848.
Shipping Conditions
Blue Ice
Storage Conditions
Store at 4°C for 2 years, do not freeze
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched

Alternative Products

CatalogName
GTR18874325-01Daratumumab (Daratumumab) ELISA KIT
abx831172-01Daratumumab
JL58276-01Human Daratumumab (Daratumumab) ELISA Kit
GTR18155547-01Daratumumab Antibody
CBA1004-01Daratumumab Biosimilar
DHD80801Research Grade Daratumumab
KDD80801Daratumumab ELISA Kit
E55B0711Daratumumab (Reference antibody)
C00026-1mgDaratumumab (anti-CD38)
GTR18605827-01Anti-CD38 [Daratumumab]

Popular Products